Fatal Septic Shock with Presumed Urinary Source in a Patient with Clinically Suspected, Previously Undiagnosed Von Hippel–Lindau Disease: A Case Report and Literature Review

Downloads

Authors

  • Talha Khan Islamic International Medical College, Riphah International University, Rawalpindi, Pakistan https://orcid.org/0009-0007-7165-2080
      Competing Interests

      No competing Interests 

    • Hasnain Wajeeh Saqib Islamic International Medical College, Riphah International University, Rawalpindi, Pakistan https://orcid.org/0009-0001-4361-5481
        Competing Interests

        No competing Interests 

      • Syed Tahir Hussain Central Park Medical College, Lahore, Pakistan
          Competing Interests

          No competing Interests 

        • Ahmad Mustafa Butt Central Park Medical College, Lahore, Pakistan https://orcid.org/0009-0001-8639-8501
            Competing Interests

            No competing Interests 

          • Muhammad Hassaan Javaid Shifa College of Medicine, Islamabad, Pakistan https://orcid.org/0009-0000-1800-1800
              Competing Interests

              No competing Interests 

            • Awais Hussain Kazim Central Park Medical College, Lahore, Pakistan
                Competing Interests

                No competing Interests 

              • Aqsa Ibrahim Central Park Medical College, Lahore, Pakistan https://orcid.org/0009-0001-6312-0259
                  Competing Interests

                  No competing Interests 

                • Saif Ali Khan Central Park Medical College, Lahore, Pakistan
                    Competing Interests

                    No competing Interests 

                  • Noor Ül-Izza Central Park Medical College, Lahore, Pakistan
                      Competing Interests

                      No competing Interests 

                    • Abdullah Abbas Central Park Medical College, Lahore, Pakistan
                        Competing Interests

                        No competing Interests 

                      DOI:

                      https://doi.org/10.71079/ASIDE.IM.062426791

                      Abstract

                      Background: Von Hippel-Lindau disease is a rare form of autosomal dominant cancer syndrome that affects multiple organs, such as the retina and brain hemangioblastoma, renal disease, and other visceral malignancies. Delayed diagnosis is a significant reason for avoidable mortality and morbidity.

                      Case Presentation: We present a case of a 47-year-old male presenting with fever, vomiting, hypotension, and pus discharge from his urethral catheter, developing into septic shock with multiple organ dysfunction syndrome. He had several decades of progressive symptoms clinically compatible with possible VHL syndrome, consisting of bilateral blindness secondary to globe enucleations performed since childhood, multifocal spinal cord lesions resulting in quadriparesis and neurogenic bladder, and a family history of retinoblastoma, brain tumors, and renal lesions. MRI of the spine showed extensive multifocal intramedullary enhancing lesions, from the cervicomedullary junction to T11, associated with dilated cord due to cystic changes, compression of the posterior medulla leading to obstructive hydrocephalus, and an occipital lesion. These findings favored multiple spinal hemangioblastomas. A corticomedullary cyst of the right kidney was seen. Despite intensive supportive therapy and appropriate broad-spectrum antibiotics, he succumbed to septic shock complicated by a presumed urinary source on hospital day 4.

                      Conclusion: This particular case illustrates the potential of unidentified genetic tumors resulting in significant neurological problems and infections leading to death. Early detection of multifocal hemangioblastomas and retinal problems can lead to early identification of patients at risk of developing VHL disease.

                      Keywords:

                      Von Hippel–Lindau disease, Hemangioblastoma, Urosepsis, Septic shock, Spinal cord tumor, Retinal hemangioblastoma, Phthisis bulbi, Delayed diagnosis, Hereditary tumor syndrome

                      References

                      1. Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM, Oldfield EH. von Hippel-Lindau disease. Lancet. 2003: 2059 [PMID: 12814730 10.1016/S0140-6736(03)13643-4] DOI: https://doi.org/10.1016/S0140-6736(03)13643-4

                      2. Maher ER, Neumann HP, Richard S. von Hippel-Lindau disease: a clinical and scientific review. Eur J Hum Genet. 2011: 617 [PMID: 21386872 10.1038/ejhg.2010.175] DOI: https://doi.org/10.1038/ejhg.2010.175

                      3. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 1993: 1317 [PMID: 8493574 10.1126/science.8493574] DOI: https://doi.org/10.1126/science.8493574

                      4. Kaelin WG, Jr. The VHL Tumor Suppressor Gene: Insights into Oxygen Sensing and Cancer. Trans Am Clin Climatol Assoc. 2017: 298 [PMID: 28790514

                      5. Van Leeuwaarde RS, Ahmad S, van Nesselrooij B, Giles RH. Von Hippel-Lindau Syndrome. GeneReviews [Internet]. Seattle (WA): University of Washington; 2024.

                      6. Melmon KL, Rosen SW. Lindau's Disease. Review of the Literature and Study of a Large Kindred. Am J Med. 1964: 595 [PMID: 14142412 10.1016/0002-9343(64)90107-x] DOI: https://doi.org/10.1016/0002-9343(64)90107-X

                      7. Louise MBM, Smerdel M, Borgwadt L, Beck Nielsen SS, Madsen MG, Moller HU, Kiilgaard JF, Friis-Hansen L, Harbud V, Cortnum S, Owen H, Gimsing S, Friis Juhl HA, Munthe S, Geilswijk M, Rasmussen AK, Moldrup U, Graumann O, Donskov F, Gronbaek H, Stausbol-Gron B, Schaffalitzky de Muckadell O, Knigge U, Dam G, Wadt KA, Bogeskov L, Bagi P, Lund L, Stochholm K, Ousager LB, Sunde L. von Hippel-Lindau disease: Updated guideline for diagnosis and surveillance. Eur J Med Genet. 2022: 104538 [PMID: 35709961 10.1016/j.ejmg.2022.104538] DOI: https://doi.org/10.1016/j.ejmg.2022.104538

                      8. Crossey PA, Eng C, Ginalska-Malinowska M, Lennard TW, Wheeler DC, Ponder BA, Maher ER. Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma. J Med Genet. 1995: 885 [PMID: 8592333 10.1136/jmg.32.11.885] DOI: https://doi.org/10.1136/jmg.32.11.885

                      9. Varshney N, Kebede AA, Owusu-Dapaah H, Lather J, Kaushik M, Bhullar JS. A Review of Von Hippel-Lindau Syndrome. J Kidney Cancer VHL. 2017: 20 [PMID: 28785532 10.15586/jkcvhl.2017.88] DOI: https://doi.org/10.15586/jkcvhl.2017.88

                      10. Acharya A, Panigrahi S, Mahapatra AK, Deo RC, Senapati SB. Von-Hippel Lindau (VHL) syndrome with bilateral cerebellar hemangioblastomas and retinal angiomas: A rare presentation. Int J Surg Case Rep. 2023: 108188 [PMID: 37080144 10.1016/j.ijscr.2023.108188] DOI: https://doi.org/10.1016/j.ijscr.2023.108188

                      11. Setyawan NH, Hartanto RA, Malueka RG, Dwianingsih EK, Dharma DP. Dual manifestations: spinal and cerebellar hemangioblastomas indicative of von Hippel-Lindau syndrome. Radiol Case Rep. 2024: 5000 [PMID: 39247472 10.1016/j.radcr.2024.07.158] DOI: https://doi.org/10.1016/j.radcr.2024.07.158

                      12. Kreatsoulas DC, Lonser RR. Spinal cord hemangioblastomas in von Hippel-Lindau disease. Neurooncol Adv. 2024: iii66 [PMID: 39430395 10.1093/noajnl/vdad153] DOI: https://doi.org/10.1093/noajnl/vdad153

                      13. Kim OH. Multifocal Spinal Hemangioblastoma in von Hippel-Lindau Syndrome: A Case Report and Literature Review. Journal of the Korean Society of Radiology. 2015: 10.3348/jksr.2015.72.3.171] DOI: https://doi.org/10.3348/jksr.2015.72.3.171

                      14. Nguyen TH, Pham T, Strickland T, Brewer D, Belirgen M, Al-Rahawan MM. Von Hippel-Lindau with early onset of hemangioblastoma and multiple drop-metastases like spinal lesions: A case report. Medicine (Baltimore). 2018: e12477 [PMID: 30278534 10.1097/MD.0000000000012477] DOI: https://doi.org/10.1097/MD.0000000000012477

                      15. Jonasch E, Donskov F, Iliopoulos O, Rathmell WK, Narayan VK, Maughan BL, Oudard S, Else T, Maranchie JK, Welsh SJ, Thamake S, Park EK, Perini RF, Linehan WM, Srinivasan R, Investigators MK. Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease. N Engl J Med. 2021: 2036 [PMID: 34818478 10.1056/NEJMoa2103425] DOI: https://doi.org/10.1056/NEJMoa2103425

                      16. Fallah J, Brave MH, Weinstock C, Mehta GU, Bradford D, Gittleman H, Bloomquist EW, Charlab R, Hamed SS, Miller CP, Dorff SE, Chambers WA, Mixter BD, Dinin J, Pierce WF, Ricks TK, Tang S, Donoghue M, Pazdur R, Amiri-Kordestani L, Ibrahim A, Beaver JA. FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease-Associated Tumors. Clin Cancer Res. 2022: 4843 [PMID: 35727604 10.1158/1078-0432.CCR-22-1054] DOI: https://doi.org/10.1158/1078-0432.CCR-22-1054

                      17. Karimi S, Arabi A, Shahraki T, Safi S. Von Hippel-Lindau Disease and the Eye. J Ophthalmic Vis Res. 2020: 78 [PMID: 32095212 10.18502/jovr.v15i1.5950] DOI: https://doi.org/10.18502/jovr.v15i1.5950

                      18. Chew EY. Ocular manifestations of von Hippel-Lindau disease: clinical and genetic investigations. Trans Am Ophthalmol Soc. 2005: 495 [PMID: 17057815

                      Downloads

                      Share this article

                      Published

                      2026-06-24

                      How to Cite

                      1.
                      Khan T, Wajeeh Saqib H, Tahir Hussain S, et al. Fatal Septic Shock with Presumed Urinary Source in a Patient with Clinically Suspected, Previously Undiagnosed Von Hippel–Lindau Disease: A Case Report and Literature Review. ASIDE Int Med. 2026;2(6):34-40. doi:10.71079/ASIDE.IM.062426791

                      Article history

                      Received
                      23 Apr 2026
                      Received in revised form
                      16 May 2026
                      Accepted
                      6 Jun 2026
                      Published
                      24 Jun 2026